Organised by:
SCI’s Fine Chemicals Group the CEO will be attending this conference on 2nd Dec 2026.
Synopsis
Protein-protein interactions are fundamental to nearly all cellular processes and are interesting targets for chemical biology research and drug development. As technology improves, so does our ability to interrogate these key interactions in both healthy and disease states, helping further the development of novel tools and identify opportunities for addressing unmet clinical need.